MA26482A1 - Composition pharmaceutique a residence gastrique. - Google Patents

Composition pharmaceutique a residence gastrique.

Info

Publication number
MA26482A1
MA26482A1 MA25037A MA25037A MA26482A1 MA 26482 A1 MA26482 A1 MA 26482A1 MA 25037 A MA25037 A MA 25037A MA 25037 A MA25037 A MA 25037A MA 26482 A1 MA26482 A1 MA 26482A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
gastric residence
gastric
residence
pharmaceutical
Prior art date
Application number
MA25037A
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of MA26482A1 publication Critical patent/MA26482A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
MA25037A 1997-04-18 1998-04-17 Composition pharmaceutique a residence gastrique. MA26482A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique

Publications (1)

Publication Number Publication Date
MA26482A1 true MA26482A1 (fr) 2004-12-20

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25037A MA26482A1 (fr) 1997-04-18 1998-04-17 Composition pharmaceutique a residence gastrique.

Country Status (19)

Country Link
EP (1) EP0983065A1 (fr)
JP (1) JP2001523241A (fr)
KR (1) KR20010006353A (fr)
CN (1) CN1252720A (fr)
AR (1) AR015586A1 (fr)
AU (1) AU737634B2 (fr)
CA (1) CA2286081A1 (fr)
FR (1) FR2762213B1 (fr)
HU (1) HUP0002455A3 (fr)
IL (1) IL131995A0 (fr)
JO (1) JO2017B1 (fr)
MA (1) MA26482A1 (fr)
NO (1) NO995039L (fr)
NZ (1) NZ500288A (fr)
PE (1) PE68199A1 (fr)
PL (1) PL336273A1 (fr)
TN (1) TNSN98049A1 (fr)
WO (1) WO1998047506A1 (fr)
ZA (1) ZA983258B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (fr) 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
ES2536836T3 (es) * 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
BR112020011189A2 (pt) 2017-12-05 2020-11-17 Sunovion Pharmaceuticals Inc. misturas não racêmicas e usos das mesmas
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
US20220323409A1 (en) * 2019-06-04 2022-10-13 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
CA3142355A1 (fr) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Formulations a liberation modifiee et utilisations associees
WO2023214018A1 (fr) 2022-05-06 2023-11-09 Galenix Innovations Composition à libération prolongée gonflable à rétention gastrique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (fr) * 1990-04-23 1991-10-24 Andrew B. Dennis Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation

Also Published As

Publication number Publication date
TNSN98049A1 (fr) 2005-03-15
AU7341698A (en) 1998-11-13
CN1252720A (zh) 2000-05-10
FR2762213B1 (fr) 1999-05-14
CA2286081A1 (fr) 1998-10-29
EP0983065A1 (fr) 2000-03-08
IL131995A0 (en) 2001-03-19
HUP0002455A2 (hu) 2000-12-28
PL336273A1 (en) 2000-06-19
AU737634B2 (en) 2001-08-23
PE68199A1 (es) 1999-07-15
NO995039D0 (no) 1999-10-15
JO2017B1 (en) 1999-05-15
WO1998047506A1 (fr) 1998-10-29
AR015586A1 (es) 2001-05-16
JP2001523241A (ja) 2001-11-20
NZ500288A (en) 2001-03-30
FR2762213A1 (fr) 1998-10-23
KR20010006353A (ko) 2001-01-26
HUP0002455A3 (en) 2001-01-29
ZA983258B (en) 1998-10-19
NO995039L (no) 1999-12-17

Similar Documents

Publication Publication Date Title
MA26549A1 (fr) Medicaments
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
DK0783302T3 (da) Lægemidler
NO994003L (no) Farmasoytisk blanding
TR199600292A2 (tr) Pestisidal karisim.
ZA9811504B (en) Novel pharmaceutical.
DK1017392T3 (da) Lægemiddel
BR9610214A (pt) Compostos farmacéuticos
MA26482A1 (fr) Composition pharmaceutique a residence gastrique.
ZA9811505B (en) Novel pharmaceutical.
EE9900545A (et) Farmatseutiline kompositsioon
BR9600809A (pt) Medicamento
ITBO970117A0 (it) Convogliatore.
ID20957A (id) Produk kembang gula kunyah
MA26531A1 (fr) Composition pharmaceutique
NO954702D0 (no) Aryldannende medikamenter
NL1001569C1 (nl) Mengtransportinrichting.
TR199601018A1 (tr) Farmasötik bilesikler.
MA26677A1 (fr) Medicaments antiparkinsoniens.
ZA982558B (en) Novel Pharmaceutical.
EP0790829A4 (fr) Medicaments
FR2772264B1 (fr) Pilulier
ES1024681Y (es) Mingitorio canino.
UA25523A (uk) Лікувальhий препарат гірчичhик